FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and represents a pharmaceutical composition in the form of a cream or gel for treating a herpes viral infection, containing 4,6-di(3,12-diaza-6,9-diazoniadispiro[5,2,5,2]hexadecan-1-yl)-2-methyl-5-nitropyrimidine tetrachloride dihydrochloride hexahydrate. The invention consists in a method of treating or preventing a herpetic infection in a human or animal.
EFFECT: providing a pharmaceutical composition of 4,6-di(3,12-diaza-6,9-diazoniadispiro[5,2,5,2]hexadecan-1-yl)-2-methyl-5-nitropyrimidine tetrachloride dihydrochloride hexahydrate in the form of a dosage form for local application possessing a high level of therapeutic efficacy.
4 cl, 2 dwg, 2 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF DI(DIAZONIADISPIRO[5.2.5.2]HEXADECANE)-5-NITROPYRIMIDINE AND THEIR USE FOR TREATMENT OF CORONAVIRUS INFECTIONS, IN PARTICULAR CAUSED BY SARS-COV-2 VIRUS | 2020 |
|
RU2761950C1 |
| PYRIMIDYL-DI(DIAZADISPIROALKANE)S WITH ANTIVIRAL ACTIVITY | 2015 |
|
RU2633699C2 |
| PHARMACEUTICAL COMPOSITION FOR HERPES TREATMENT | 1998 |
|
RU2165264C2 |
| MEANS FOR PREVENTING AND ARRESTING HERPES VIRUS INFECTION MANIFESTATIONS ON SKIN AND MUCOUS MEMBRANES | 2000 |
|
RU2175540C2 |
| -4-[6-(PURINE-6-YLAMINO)HEXANOYL]-3,4-DIHYDRO-3-METHYL-7,8-DIFLUOR-2H-[1,4]BENZOXAZINE AND (3R)-4-[6-(PURINE-6-YLAMINO)HEXANOYL]-3,4-DIHYDRO-3-METHYL-7,8-DIFLUOR-2H-[1,4]BENZOXAZINE WITH ANTIVIRAL ACTIVITY | 2016 |
|
RU2644351C1 |
| COMPLEXES OF GERMANIUM WITH PURINE NITROGENOUS BASES, METHODS FOR PRODUCTION THEREOF AND MEDICINAL AGENTS CONTAINING SAID COMPLEXES | 2012 |
|
RU2487878C1 |
| AGENT POSSESSING BIOCIDAL ACTION | 2017 |
|
RU2673807C2 |
| ANTIVIRAL ACTIVITY OF FULLERENE AQUEOUS SOLUTION | 2018 |
|
RU2694754C1 |
| NUCLEOSIDE DERIVATIVES OF 1,3-DIAZA-2-OXOPHENOXAZINE AS HERPESVIRUS REPLICATION INHIBITORS | 2019 |
|
RU2731381C1 |
| USE OF LIOPHILISED PREPARATION OF ALLOFIBROBLASTS FOR TREATING HERPES VIRUS DISEASES | 2012 |
|
RU2483739C1 |
